SCHEMBL9467285

SCHEMBL9467285

O=C(CCC1Cc2ccccc21)N1CCN(c2cccc3c2OC=CCO3)CC1

nearest known ligand 0.51

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.41
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9467283 0.93 HTR1A (0.41) HTR1APOLB
SCHEMBL9183283 0.85 HTR1A (0.56) HTR1A
SCHEMBL9685587 0.84
SCHEMBL9177843 0.82
SCHEMBL9173735 0.81 HTR1A (0.43) HTR1A
SCHEMBL9467135 0.77 HTR1A (0.51) HTR1A
SCHEMBL9467347 0.76
SCHEMBL9685582 0.76
SCHEMBL9183269 0.76 POLB (0.39) POLB
SCHEMBL9177834 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5194437-A Substituted with oxygen containing heterocycle, central nervous system disorders, neuroendocrine disorders ADIR ET COMPAGNIE (FR) 1993-03-16 US disclosed
EP-0490772-A1 1,4-Disubstituted piperazines, their process of preparation and pharmaceutical compositions containing them ADIR ET COMPAGNIE (FR) 1992-06-17 EP disclosed